Kura Oncology: Sentiment Is Too Negative
Kura Oncology's stock plummeted 50% after announcing a collaboration with Kyowa Kirin, making it a less attractive ...
Kura Oncology (KURA) Gets a Buy from Jefferies
In a report released today, Roger Song from Jefferies maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target of ...
ETF Daily News15 天
Kura Oncology Signs Lease Agreement for New Executive Offices
an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid ...
The Lancet20 天
Evidence for a reduction in number of cycles of immune checkpoint inhibitors
A separate retrospective analysis of a larger cohort of 1091 patients with advanced NSCLC who were progression-free after at least 2 years of immune checkpoint inhibitor therapy similarly did not find ...
ETF Daily News29 天
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $29.86
an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid ...
C&EN29 天
Strategic Acyl Carrier Protein Engineering Enables Functional Type II Polyketide Synthase ...
Faculty of Chemistry and Earth Sciences, Institute for Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany Department of Paleobiotechnology, Leibniz ...